Tech Company Financing Transactions
Recida Therapeutics Funding Round
Recida Therapeutics closed a $8.5 million Series A investment round on 2/7/2019. Investors included Frazier Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
2/7/2019
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Frazier Healthcare Partners (Lead Investor) (Patrick Heron)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
70 Willow Rd. 200
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Email Address
Not Recorded
Overview
Recida Therapeutics is a Biotechnology company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yigong Ge
Browse more venture capital transactions:
Prev: 2/7/2019: eCare Vault venture capital transaction
Next: 2/7/2019: Outlaw venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs